ANCILLARE IN THE NEWS
Keep up with the latest from the category leader READ THE NEWSTRADESHOW SCHEDULENews
Our most recent announcements.
Ancillare Launches Employee Training and Development Program, Offers Tuition Assistance
Global Clinical Trial Ancillary Supply Chain (CTASC™) leader Ancillare, LP, the first and only Life Sciences company dedicated to Ancillary Supply Chain for Phase I-IV clinical research, is proud to announce the official launch of Ancillare University, a set of professional development courses for its staff.
Ancillare Joins Decentralized Trials & Research Alliance (DTRA)
Global Clinical Trial Ancillary Supply Chain (CTASC™) leader Ancillare, LP, the first and only Life Sciences company dedicated to Ancillary Supply Chain for Phase I-IV clinical research, announced today it has joined the Decentralized Trials & Research Alliance (DTRA), an historic alliance of over one hundred life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.
Ancillare Purchases Property Within U.S. Pharma Hub, Begins Facility Renovation
Strategically located in Greater Philadelphia, the new property is the second location owned by Ancillare within the pharma corridor of the northeastern United States. The company plans to renovate the space to accommodate expansion of its core capabilities, including kitting, labeling, and Direct-to-Patient operations.
Ancillare Appoints Vice President of Supply Chain
Christopher Calabretta, an accomplished procurement and operations executive, brings three decades of supply chain expertise to Ancillare’s leadership team.
Tradeshow Schedule
Meet with us at any of the industry tradeshows on our schedule to learn the latest on Clinical Trial Ancillary Supply Chain (CTASC™) Management.
Outsourcing in Clinical Trials – New England
Boston, MA
Can't Meet with Us in Person This Year?
Tell us a little about your project or ancillary supply challenges, and we will set-up a complimentary consultation with our team.